of whole-genome sequencing and whole-genome genotyping are rapidly decreasing,' Venter and his colleagues observe. 'Companies such as Navigenics, 23andMe, and deCODE will genotype 600,000 to 1,000,000 markers in an effort to offer personalized genomics;...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Race, genes, and the future of medicine.
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account